Daniela V. Wenge

472 total citations
12 papers, 60 citations indexed

About

Daniela V. Wenge is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Daniela V. Wenge has authored 12 papers receiving a total of 60 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 7 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Daniela V. Wenge's work include Protein Degradation and Inhibitors (7 papers), Acute Myeloid Leukemia Research (6 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Daniela V. Wenge is often cited by papers focused on Protein Degradation and Inhibitors (7 papers), Acute Myeloid Leukemia Research (6 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Daniela V. Wenge collaborates with scholars based in United States, Germany and Switzerland. Daniela V. Wenge's co-authors include Scott A. Armstrong, Christoph Schliemann, Florian Perner, Wallace Bourgeois, Eric S. Fischer, Jevon Cutler, Jörn C. Albring, John G. Doench, Matthias Stelljes and Ross L. Levine and has published in prestigious journals such as Blood, Cancer Research and Cell Reports.

In The Last Decade

Daniela V. Wenge

10 papers receiving 60 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniela V. Wenge United States 6 38 37 13 12 5 12 60
Eva A. Coenen Netherlands 5 25 0.7× 22 0.6× 10 0.8× 8 0.7× 6 1.2× 6 42
Valentine Richez France 3 20 0.5× 31 0.8× 12 0.9× 5 0.4× 5 1.0× 8 38
Caroline Almon United States 6 39 1.0× 34 0.9× 10 0.8× 5 0.4× 11 2.2× 8 61
Claudia Saitta Italy 5 41 1.1× 33 0.9× 4 0.3× 10 0.8× 9 1.8× 8 70
Émilie Lemasle France 4 27 0.7× 53 1.4× 8 0.6× 11 0.9× 17 3.4× 9 62
Souhila Ikhlef France 4 38 1.0× 58 1.6× 46 3.5× 14 1.2× 6 1.2× 5 77
Jason Van Oostendorp United Kingdom 2 40 1.1× 47 1.3× 7 0.5× 10 0.8× 10 2.0× 4 54
Lisa Gu United States 4 39 1.0× 33 0.9× 10 0.8× 10 0.8× 4 0.8× 5 66
Sumithra Vasu United States 5 19 0.5× 42 1.1× 10 0.8× 8 0.7× 7 1.4× 9 49
Marta Reinoso Segura Spain 4 29 0.8× 44 1.2× 22 1.7× 3 0.3× 3 0.6× 5 44

Countries citing papers authored by Daniela V. Wenge

Since Specialization
Citations

This map shows the geographic impact of Daniela V. Wenge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela V. Wenge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela V. Wenge more than expected).

Fields of papers citing papers by Daniela V. Wenge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniela V. Wenge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela V. Wenge. The network helps show where Daniela V. Wenge may publish in the future.

Co-authorship network of co-authors of Daniela V. Wenge

This figure shows the co-authorship network connecting the top 25 collaborators of Daniela V. Wenge. A scholar is included among the top collaborators of Daniela V. Wenge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniela V. Wenge. Daniela V. Wenge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Godfrey, Laura, Charlie Hatton, Daniela V. Wenge, et al.. (2025). p300/CBP is an essential driver of pathogenic enhancer activity and gene expression in Ewing sarcoma. EMBO Reports. 26(19). 4766–4793. 1 indexed citations
2.
Wenge, Daniela V. & Scott A. Armstrong. (2025). Menin inhibition for the treatment of acute leukemia. Seminars in Hematology. 62(3). 187–195.
3.
Bourgeois, Wallace, Jevon Cutler, Daniela V. Wenge, et al.. (2024). Discerning the Landscape of Menin Inhibitor Resistance. Blood. 144(Supplement 1). 724–724. 6 indexed citations
4.
Heikamp, Emily, Cynthia Martucci, Dana S. Neel, et al.. (2024). NUP98 fusion proteins and KMT2A-MENIN antagonize PRC1.1 to drive gene expression in AML. Cell Reports. 43(11). 114901–114901. 5 indexed citations
5.
Wenge, Daniela V. & Scott A. Armstrong. (2023). The future of HOXA-expressing leukemias: Menin inhibitor response and resistance. Current Opinion in Hematology. 31(2). 64–70. 11 indexed citations
6.
Perner, Florian, Homa Rahnamoun, Daniela V. Wenge, et al.. (2023). S125: NON-GENETIC RESISTANCE TO MENIN INHIBITION IN AML IS REVERSIBLE BY PERTURBATION OF KAT6A. HemaSphere. 7(S3). e6233123–e6233123. 5 indexed citations
7.
Cutler, Jevon, Jonathan M. Tsai, Wallace Bourgeois, et al.. (2023). Menin Inhibitor Induced Menin Protein Degradation Contributes to Menin Inhibitor Efficacy. Blood. 142(Supplement 1). 2788–2788. 2 indexed citations
8.
Perner, Florian, Sheng F. Cai, Daniela V. Wenge, et al.. (2023). Abstract 3457: Characterization of acquired resistance mutations to menin inhibitors. Cancer Research. 83(7_Supplement). 3457–3457. 7 indexed citations
9.
Wenge, Daniela V., Klaus Wethmar, Tim Sauer, et al.. (2022). Characteristics and Outcome of Elderly Patients (>55 Years) with Acute Lymphoblastic Leukemia. Cancers. 14(3). 565–565. 3 indexed citations
10.
Wenge, Daniela V., Klaus Wethmar, Jan‐Henrik Mikesch, et al.. (2021). Allogeneic hematopoietic stem cell transplantation for therapy-related myeloid neoplasms following treatment of a lymphoid malignancy. Leukemia & lymphoma. 62(8). 1930–1939.
11.
Stelmach, Patrick, Klaus Wethmar, Christoph Groth, et al.. (2020). Blinatumomab or Inotuzumab Ozogamicin as Bridge to Allogeneic Stem Cell Transplantation for Relapsed or Refractory B-lineage Acute Lymphoblastic Leukemia: A Retrospective Single-Center Analysis. Clinical Lymphoma Myeloma & Leukemia. 20(10). e724–e733. 10 indexed citations
12.
Wenge, Daniela V., Linus Angenendt, Christoph Schliemann, et al.. (2015). MN1–Fli1 oncofusion transforms murine hematopoietic progenitor cells into acute megakaryoblastic leukemia cells. Oncogenesis. 4(12). e179–e179. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eva A. Coenen Breakdown of academic impact, for papers by Valentine Richez Breakdown of academic impact, for papers by Caroline Almon Breakdown of academic impact, for papers by Claudia Saitta Breakdown of academic impact, for papers by Émilie Lemasle Breakdown of academic impact, for papers by Souhila Ikhlef Breakdown of academic impact, for papers by Jason Van Oostendorp Breakdown of academic impact, for papers by Lisa Gu Breakdown of academic impact, for papers by Sumithra Vasu Breakdown of academic impact, for papers by Marta Reinoso Segura
Rankless by CCL
2026